This Healthcare Stock is Soaring Following Exclusive License Agreement Announcement
Tuesday, 19 November 2024 ()
A %Healthcare company based out of Pennsylvania caused quite the stir on Tuesday after the company announced that it had entered into an exclusive license agreement with Biosion Inc. for worldwide rights (excluding Greater China) to BSI-045B and BSI-502, a preclinical-stage, novel bispecific antibody directed against both TSLP and IL4R, according to a release. Traders […]
|
||||
|
|
||||
You Might Like |
||||
